Inmune Bio, Inc. (INMB) earnings
Quarterly results of Inmune Bio, Inc. as filed with the SEC: revenue, net income and earnings per share for each of the last 8 quarters, the latest results release and when the next one is expected.
Next earnings date
Inmune Bio, Inc. was expected to report around October 29, 2026; nothing is on file with the SEC yet.
Latest quarter: Q2 FY2026
In Q2 FY2026 (ended June 30, 2026) Inmune Bio, Inc. reported revenue of - and a net loss of $1.3M.
Diluted earnings per share were -$0.05.
Quarter by quarter
| Quarter | Revenue | vs year ago | Net income | EPS |
|---|---|---|---|---|
| Q2 FY2026 | - | - | -$1.3M | -$0.05 |
| Q1 FY2026 | - | - | -$5.4M | -$0.20 |
| Q4 FY2025 | - | - | -$5.3M | - |
| Q3 FY2025 | - | - | -$6.5M | -$0.24 |
| Q2 FY2025 | - | - | -$24.5M | -$1.05 |
| Q1 FY2025 | $50K | - | -$9.7M | -$0.43 |
| Q4 FY2024 | - | - | -$9.2M | - |
| Q3 FY2024 | - | - | -$12.1M | -$0.60 |
Results filings
- Quarterly report 10-Q
- Quarterly report 10-Q
- Annual report 10-K
When is Inmune Bio, Inc.'s next earnings date?
Inmune Bio, Inc. was expected to report around October 29, 2026; nothing is on file with the SEC yet.
Get an email when INMB reports
Follow INMB and we email you its next results the day they are filed, with the numbers explained.